News | July 16, 2025
Waters, BD biosciences unit agree to $17.5 billion merger
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Adjusted EBITDA positive at Rs. 3.1 crore despite investments in marketing, talent hiring and technology over the year
Alembic Pharmaceuticals commissions new facility at Pithampur
This unit will focus on the manufacturing of health and wellness equipment
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Subscribe To Our Newsletter & Stay Updated
